These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6771507)

  • 21. The effect of spironolactone pretreatment on the biliary excretion of digitoxin and its metabolites in male and female rats.
    Kitani K; Sato Y; Kanai S; Nokubo M
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):355-73. PubMed ID: 7178649
    [No Abstract]   [Full Text] [Related]  

  • 22. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
    Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
    Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of organ dysfunction on drug dosing.
    Egorin M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):116-8. PubMed ID: 16728919
    [No Abstract]   [Full Text] [Related]  

  • 24. [Problematic drug interactions].
    Neuvonen PJ; Kivistö K
    Duodecim; 1998; 114(10):1039-48. PubMed ID: 11524778
    [No Abstract]   [Full Text] [Related]  

  • 25. [Digitoxin--rediscovered].
    Fischer M
    Med Klin; 1980 Dec; 75(25):891-3. PubMed ID: 7464638
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
    Tang J; Amin Usmani K; Hodgson E; Rose RL
    Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species difference in duration of action of cardiac glycosides.
    Okita GT
    Fed Proc; 1967; 26(4):1125-30. PubMed ID: 6028775
    [No Abstract]   [Full Text] [Related]  

  • 28. Selected examples of biochemical-toxicological problems.
    Deckert FW
    Drug Metab Rev; 1979; 10(2):285-98. PubMed ID: 399460
    [No Abstract]   [Full Text] [Related]  

  • 29. The quinidine-digoxin interaction in patients with impaired renal function.
    Fichtl B; Doering W; Seidel H
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):229-33. PubMed ID: 6862727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of drug-metabolizing systems by bacterial endotoxin in carp liver and immune organs.
    Marionnet D; Chambras C; Taysse L; Bosgireaud C; Deschaux P
    Ecotoxicol Environ Saf; 1998 Oct; 41(2):189-94. PubMed ID: 9756707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycin.
    Pessayre D; Descatoire V; Tinel M; Larrey D
    J Pharmacol Exp Ther; 1982 Apr; 221(1):215-21. PubMed ID: 6977641
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug interactions as a cause for iatrogenic diseases in the aged. A tabulated presentation].
    Hitzenberger G
    Aktuelle Gerontol; 1983 Sep; 13(5):173-6. PubMed ID: 6139032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
    Kuhlmann J
    Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of drug metabolism: species differences and toxicological relevance.
    Graham MJ; Lake BG
    Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Foreign substance-degrading enzyme system of the human liver. Modification by alcohol, other exogenous factors and liver diseases].
    Hoensch HP
    Fortschr Med; 1981 May; 99(20):784-7. PubMed ID: 6790394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Digoxin or digitoxin? Glycoside choice in old age and in kidney and liver diseases].
    Kolenda KD; Jost S; Kokenge F
    Ther Ggw; 1981 Jan; 120(1):21-39. PubMed ID: 7233344
    [No Abstract]   [Full Text] [Related]  

  • 37. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA.
    Takahashi T; Lasker JM; Rosman AS; Lieber CS
    Hepatology; 1993 Feb; 17(2):236-45. PubMed ID: 8428720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug therapy in impaired liver and kidney function].
    Galeazzi RL
    Schweiz Med Wochenschr; 1983 May; 113(20):726-32. PubMed ID: 6879125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction and inhibition of CYPs and implications for medicine.
    Murray M
    Mol Aspects Med; 1999; 20(1-2):24-33, 34-137. PubMed ID: 10575649
    [No Abstract]   [Full Text] [Related]  

  • 40. Concurrent session: drug metabolism and the liver.
    Med J Aust; 1971 Sep; 2(12):Suppl 3:21-2. PubMed ID: 5114183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.